STAT+: AI drug firm Recursion moves from survival to industry domination
STAT
AUGUST 19, 2024
. The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.
Let's personalize your content